Assessment of tumor biomarkers based on a Turkish city hospital’s data

View Full Paper

Ask AI

Bookmark

Frequency of positive test results for CA 15-3 was 3.5%, while CA 19-9 was 12.6%, revealing notable prevalence rates.
Statistical differences were observed across genders for several biomarkers, with CA 19-9 showing a p-value of 0.016.
Testing orders for tumor biomarkers may lack specific diagnostic purposes, potentially leading to unnecessary patient anxiety.
Clinicians need to assess the rationale for ordering tumor biomarker tests, as inappropriate tests can inflate healthcare costs.

Discussion

No takes yet. Share an insight, caveat, or question.

Observational analysis shows variations in tumor biomarkers among genders and age groups in Ankara, indicating testing concerns.

Gök et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark